Notify me when Krensavage Asset Management, LLC files a new 13F portfolio report.
⭐ Subscribe ⭐| Quarter | Holdings | Value $ | Bought | Sold | Net | Top Holdings | Form Type | Filing Time |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | 18 | $283,112,000 | +$22,734,356 | -$20,216,504 | +$2,517,852 | UTHR, ENTA, BMRN, JAZZ, EXEL | 13F-HR | 17 Feb 2026, 21:26 |
| Q3 2025 | 17 | $234,698,000 | +$35,027,843 | -$37,553,410 | -$2,525,567 | UTHR, ENTA, JAZZ, BMRN, EXEL | 13F-HR | 14 Nov 2025, 19:55 |
| Q2 2025 | 15 | $188,935,000 | +$18,614,549 | -$27,841,695 | -$9,227,146 | UTHR, CAH, EXEL, JAZZ, ENTA | 13F-HR | 14 Aug 2025, 20:48 |
| Q1 2025 | 14 | $180,885,000 | +$36,033,691 | -$24,394,648 | +$11,639,043 | EXEL, UTHR, CAH, SUPN, JAZZ | 13F-HR | 15 May 2025, 15:48 |
| Q4 2024 | 12 | $169,025,000 | +$6,467,415 | -$16,405,345 | -$9,937,930 | UTHR, EXEL, CAH, BIIB, JAZZ | Restatement | 18 Feb 2025, 16:15 |
| Q3 2024 | 13 | $178,461,000 | +$9,533,289 | -$61,460,192 | -$51,926,903 | UTHR, EXEL, CAH, BIIB, ENTA | 13F-HR | 14 Nov 2024, 19:04 |
| Q2 2024 | 13 | $217,801,000 | +$9,953,462 | -$21,338,303 | -$11,384,841 | EXEL, UTHR, BIIB, TARO, CAH | 13F-HR | 14 Aug 2024, 21:33 |
| Q1 2024 | 12 | $225,525,000 | +$17,961,161 | -$81,155,385 | -$63,194,224 | EXEL, UTHR, BIIB, TARO, CAH | 13F-HR | 15 May 2024, 16:23 |
| Q4 2023 | 12 | $281,853,000 | +$21,898,819 | -$22,551,871 | -$653,052 | EXEL, UTHR, BIIB, REGN, CAH | 13F-HR | 14 Feb 2024, 16:12 |
| Q3 2023 | 12 | $271,606,000 | +$1,946,119 | -$30,544,536 | -$28,598,417 | UTHR, EXEL, BIIB, REGN, ALKS | 13F-HR | 14 Nov 2023, 20:15 |
| Q2 2023 | 12 | $315,622,000 | +$2,220,253 | -$10,291,155 | -$8,070,902 | BIIB, UTHR, REGN, EXEL, ALKS | 13F-HR | 11 Aug 2023, 15:37 |
| Q1 2023 | 12 | $329,274,000 | +$5,541,246 | -$839,541 | +$4,701,705 | BIIB, REGN, UTHR, EXEL, ALKS | 13F-HR | 15 May 2023, 21:44 |
| Q4 2022 | 12 | $323,644,000 | +$7,430,214 | -$16,895,875 | -$9,465,661 | UTHR, BIIB, REGN, ALKS, EXEL | 13F-HR | 15 Feb 2023, 08:09 |
| Q3 2022 | 14 | $314,064,000 | +$37,405,871 | -$20,012,357 | +$17,393,514 | BIIB, UTHR, REGN, ALKS, ENTA | 13F-HR | 14 Nov 2022, 19:51 |
| Q2 2022 | 14 | $302,495,000 | +$40,801,997 | -$18,659,396 | +$22,142,601 | UTHR, ALKS, REGN, EXEL, ENTA | 13F-HR | 15 Aug 2022, 21:19 |
| Q1 2022 | 13 | $290,135,000 | +$7,574,091 | -$14,174,687 | -$6,600,596 | REGN, ENTA, MCK, ALKS, UTHR | 13F-HR | 16 May 2022, 20:50 |
| Q4 2021 | 10 | $288,314,000 | +$10,207,900 | -$47,904,392 | -$37,696,492 | UTHR, REGN, ENTA, MCK, ALKS | 13F-HR | 14 Feb 2022, 21:12 |
| Q3 2021 | 13 | $318,782,000 | +$24,928,864 | -$16,335,917 | +$8,592,947 | ENTA, ALKS, REGN, UTHR, TARO | 13F-HR | 15 Nov 2021, 17:38 |
| Q2 2021 | 13 | $294,544,000 | +$9,967,508 | -$21,931,723 | -$11,964,215 | REGN, ALKS, ENTA, UTHR, TARO | 13F-HR | 13 Aug 2021, 17:16 |
| Q1 2021 | 12 | $288,899,000 | +$916,588 | -$69,149,692 | -$68,233,104 | ENTA, UTHR, TARO, REGN, BIIB | 13F-HR | 17 May 2021, 21:01 |
| Q4 2020 | 12 | $342,426,000 | +$4,694,864 | -$24,305,566 | -$19,610,702 | ALXN, UTHR, TARO, REGN, ENTA | 13F-HR | 16 Feb 2021, 17:47 |
| Q3 2020 | 11 | $314,096,000 | +$16,633,125 | -$43,843,140 | -$27,210,015 | REGN, ALXN, UTHR, BIIB, ENTA | Restatement | 08 Dec 2020, 17:21 |
| Q2 2020 | 11 | $367,575,000 | +$33,291,068 | -$27,588,990 | +$5,702,078 | UTHR, ALXN, REGN, BIIB, ENTA | Restatement | 20 Aug 2020, 15:41 |
| Q1 2020 | 13 | $310,898,000 | +$45,554,432 | -$13,774,941 | +$31,779,491 | UTHR, REGN, ALXN, ENTA, BIIB | 13F-HR | 15 May 2020, 19:32 |
| Q4 2019 | 12 | $293,048,000 | +$101,041,816 | -$90,487,863 | +$10,553,953 | UTHR, REGN, MCK, ALXN, BIIB | 13F-HR | 14 Feb 2020, 21:59 |
| Q3 2019 | 10 | $260,445,000 | +$26,222,919 | -$52,318,678 | -$26,095,759 | UTHR, BIIB, MCK, GILD, ENTA | 13F-HR | 14 Nov 2019, 20:06 |
| Q2 2019 | 10 | $308,111,000 | +$7,815,619 | -$41,935,116 | -$34,119,497 | MCK, UTHR, BIIB, ENTA, AMGN | 13F-HR | 14 Aug 2019, 16:37 |
| Q1 2019 | 12 | $370,055,000 | +$72,089,021 | -$37,393,449 | +$34,695,572 | UTHR, MCK, ENTA, BIIB, AMGN | 13F-HR | 15 May 2019, 15:58 |
| Q4 2018 | 13 | $296,165,000 | +$5,532,052 | -$45,356,931 | -$39,824,879 | UTHR, MCK, ENTA, AMGN, GILD | Restatement | 14 Feb 2019, 18:16 |
| Q3 2018 | 14 | $389,139,000 | +$39,516,194 | -$46,259,913 | -$6,743,719 | UTHR, MCK, AMGN, ENTA, GILD | 13F-HR | 14 Nov 2018, 15:38 |
| Q2 2018 | 14 | $391,605,000 | +$11,359,836 | -$68,069,126 | -$56,709,290 | UTHR, ENTA, AMGN, MCK, GILD | 13F-HR | 13 Aug 2018, 14:51 |
| Q1 2018 | 16 | $412,201,000 | +$154,386,978 | -$79,155,529 | +$75,231,449 | UTHR, ENTA, AMGN, MCK, GILD | 13F-HR | 14 May 2018, 10:40 |
| Q4 2017 | 16 | $320,818,000 | +$41,374,477 | -$74,229,963 | -$32,855,486 | ENTA, UTHR, BIOVERATIV INC, GILD, SCMP | 13F-HR | 14 Feb 2018, 12:02 |
| Q3 2017 | 14 | $320,803,000 | +$8,907,201 | -$33,785,674 | -$24,878,473 | ENTA, GILD, UTHR, BIOVERATIV INC, SCMP | 13F-HR | 14 Nov 2017, 09:15 |
| Q2 2017 | 15 | $329,397,000 | +$18,797,197 | -$26,719,219 | -$7,922,022 | BIOVERATIV INC, ENTA, GILD, UTHR, SCMP | 13F-HR | 14 Aug 2017, 11:10 |
| Q1 2017 | 15 | $310,101,000 | +$74,115,886 | -$37,238,890 | +$36,876,996 | BIOVERATIV INC, GILD, ENTA, UTHR, SCMP | 13F-HR | 15 May 2017, 11:33 |
| Q4 2016 | 16 | $278,919,000 | +$36,313,359 | -$44,487,732 | -$8,174,373 | UTHR, ENTA, GILD, SCMP, OFIX | 13F-HR | 13 Feb 2017, 14:40 |
| Q3 2016 | 17 | $276,731,000 | +$13,375,955 | -$22,548,240 | -$9,172,285 | UTHR, OFIX, ENTA, IPXL, AMGN | 13F-HR | 14 Nov 2016, 11:12 |
| Q2 2016 | 20 | $277,542,000 | +$45,367,519 | -$46,903,573 | -$1,536,054 | UTHR, OFIX, IPXL, ENTA, TEVA | 13F-HR | 12 Aug 2016, 14:41 |
| Q1 2016 | 22 | $278,703,000 | +$5,646,797 | -$476,964 | +$5,169,833 | BXLT, OFIX, ENTA, UTHR, TEVA | 13F-HR | 13 May 2016, 11:13 |
| Q4 2015 | 22 | $313,414,000 | +$29,974,492 | -$10,908,875 | +$19,065,617 | UTHR, ENTA, BXLT, TEVA, OFIX | 13F-HR | 12 Feb 2016, 12:35 |
| Q3 2015 | 23 | $276,257,000 | +$54,485,466 | -$9,291,866 | +$45,193,600 | ENTA, UTHR, BXLT, TEVA, OFIX | 13F-HR | 13 Nov 2015, 12:13 |
| Q2 2015 | 22 | $265,146,000 | +$68,217,497 | -$31,239,000 | +$36,978,497 | ENTA, UTHR, IPXL, TEVA, HYH | 13F-HR | 13 Aug 2015, 15:28 |
| Q1 2015 | 23 | $219,568,000 | +$25,950,518 | -$13,073,089 | +$12,877,429 | UTHR, IPXL, AMAG, TEVA, HYH | 13F-HR | 13 May 2015, 16:42 |
| Q4 2014 | 26 | $179,479,000 | $0 | $0 | $0 | UTHR, AMAG, SCMP, IPXL, TEVA | 13F-HR | 18 Feb 2015, 13:17 |